Hyperprolactinaemia in male infertility: Clinical case scenariosFootnote

Peer review under responsibility of Arab Association of Urology.

References

• M.N.MascarenhasS.R.FlaxmanT.BoermaS.VanderpoelC.D.MathersG.A.StevensTrends in primary and secondary infertility prevalence since 1990: a systematic analysis of demographic and reproductive health surveysLancet3812013S90
   Web of Science ®Google Scholar
• J.BoivinL.BuntingJ.A.CollinsK.G.NygrenInternational estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical careHum Reprod22200715061512
   PubMed Web of Science ®Google Scholar
• V.M.BrughL.I.LipshultzMale factor infertility: evaluation and managementMed Clin North Am882004367385
   PubMed Web of Science ®Google Scholar
• American Urological Association. Optimal Evaluation of the Infertile Male: best practice statement reviewed and validity confirmed 2011. Available at: http://www.auanet.org/guidelines/male-infertility-optimal-evaluation-(reviewed-and-validity-confirmed-2011). Accessed October 2017.
   Google Scholar
• Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 1999; 44 (Suppl.):1075–84.
   Google Scholar
• A.MajumdarN.S.MangalHyperprolactinemiaJ Hum Reprod Sci62013168175
   PubMedGoogle Scholar
• L.KatznelsonA.KlibanskiProlactinomasCancer Treat Res8919974155
   Google Scholar
• P.SinghM.SinghG.CugatiA.K.SinghHyperprolactinemia: an often missed cause of male infertilityJ Hum Reprod Sci42011102103
   Google Scholar
• D.MoherA.LiberatiJ.TetzlaffD.G.AltmanPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ3392009b2535
   PubMed Web of Science ®Google Scholar
• N.LauferH.YaffeE.J.MargaliothJ.LivshinM.Ben-DavidJ.G.SchenkerEffect of bromocriptine treatment on male infertility associated with hyperprolactinemiaArch Androl61981343346
   PubMed Web of Science ®Google Scholar
• R.WaliaA.BhansaliP.DuttaN.KhandelwalR.SialyS.BhadadaRecovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergolineIndian J Med Res1342011314319
   PubMed Web of Science ®Google Scholar
• O.ModebeHyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatmentInt J Fertil Menopausal Stud3919949599
   PubMedGoogle Scholar
• M.De RosaA.CiccarelliS.ZarrilliE.GuerraM.GaccioneA.Di Sarnoet alThe treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic malesClin Endocrinol (Oxf)642006307313
   PubMed Web of Science ®Google Scholar
• A.ColaoG.VitaleP.CappabiancaF.BrigantiA.CiccarelliM.De Rosaet alOutcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysisJ Clin Endocrinol Metab89200417041711
   PubMed Web of Science ®Google Scholar
• M.De RosaA.ColaoA.Di SarnoD.FeroneM.L.LandiS.Zarrilliet alCabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptineEur J Endocrinol1381998286293
   PubMed Web of Science ®Google Scholar
• A.ColaoM.De RosaF.SarnacchiaroA.Di SarnoM.L.LandiE.Iervolinoet alChronic treatment with CV 205–502 restores the gonadal function in hyperprolactinemic malesEur J Endocrinol1351996548552
   PubMed Web of Science ®Google Scholar
• K.NishimuraK.MatsumiyaN.TsuboniwaM.YamanakaM.KogaH.Miuraet alBromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effectsArch Androl431999207213
   PubMed Web of Science ®Google Scholar
• Mcquaid JW, Tanrikut C. Physiology of testosterone. In: Mulhall JP, Hsiao W, editors. Men’s sexual health and fertility. A Clinician’s guide. New York: Springer Science and Business Media; 2014.
   Google Scholar
• R.TsutsumiN.J.WebsterGnRH pulsatility, the pituitary response and reproductive dysfunctionEndocr J562009729737
   PubMed Web of Science ®Google Scholar
• Hair WM, Gubbay O, Jabbour HN, Lincoln GA. Prolactin receptor expression in human testis and accessory tissues: localization and function. Mol Hum Reprod 2002;8:606–11.
   Google Scholar
• H.G.KlemckeA.G.AmadorA.BartkeHormonal regulation of testicular prolactin receptors and testosterone synthesis in golden hamstersBiol Reprod431990162168
   Web of Science ®Google Scholar
• H.N.JabbourG.A.LincolnProlactin receptor expression in the testis of the ram: localisation, functional activation and the influence of gonadotrophinsMol Cell Endocrinol1481999151161
   Web of Science ®Google Scholar
• M.B.WhyteS.PramodhL.SrikuganJ.A.GilbertJ.P.MiellR.A.Sherwoodet alImportance of cannulated prolactin test in the definition of hyperprolactinaemiaPituitary182015319325
   PubMed Web of Science ®Google Scholar
• M.AgarwalA.DasA.S.SinghHigh-dose hook effect in prolactin macroadenomas: a diagnostic concernJ Hum Reprod Sci32010160161
   Google Scholar
• M.KasumS.OreskovicI.ZecD.JezekV.TomicV.Gallet alMacroprolactinemia: new insights in hyperprolactinemiaBiochem Med (Zagreb)222012171179
   Web of Science ®Google Scholar
• C.C.LuC.J.HsiehThe importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patientsKaohsiung J Med Sci2820129499
   Web of Science ®Google Scholar
• S.MelmedF.F.CasanuevaA.R.HoffmanD.L.KleinbergV.M.MontoriJ.A.Schlechteet alDiagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab962011273288
   PubMed Web of Science ®Google Scholar
• V.S.LimS.C.KathpaliaL.A.FrohmanHyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantationJ Clin Endocrinol Metab481979101107
   PubMed Web of Science ®Google Scholar
• K.S.HonboA.J.van HerleK.A.KellettSerum prolactin levels in untreated primary hypothyroidismAm J Med641978782787
   PubMed Web of Science ®Google Scholar
• M.E.MolitchDrugs and prolactinPituitary112008209218
   PubMed Web of Science ®Google Scholar
• D.L.TorreA.FalorniPharmacological causes of hyperprolactinemiaTher Clin Risk Manag32007929951
   PubMedGoogle Scholar
• Huguet I, Clayton R. Pituitary-Hypothalamic Tumor Syndromes: Adults. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., editors. Endotext, South Dartmouth (MA): Endotext; 2000. Available at: http://https://www.ncbi.nlm.nih.gov/books/NBK278946/. Accessed Ocober 2017.
   Google Scholar
• J.SchlechteK.DolanB.ShermanF.ChaplerA.LucianoThe natural history of untreated hyperprolactinemia: a prospective analysisJ Clin Endocrinol Metab681989412418
   PubMed Web of Science ®Google Scholar
• Wang AT1, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 2012;1:33.
   Google Scholar
• Webster J, Piscitelli G, Polli A, D'Alberton A, Falsetti L, Ferrari C et al. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf) 1992; 37:534–41.
   Google Scholar
• A.ColaoA.Di SarnoM.L.LandiF.ScavuzzoP.CappabiancaR.Pivonelloet alMacroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patientsJ Clin Endocrinol Metab85200022472252
   PubMed Web of Science ®Google Scholar
• J.J.PinzoneL.KatznelsonD.C.DanilaD.K.PaulerC.S.MillerA.KlibanskiPrimary medical therapy of micro- and macroprolactinomas in menJ Clin Endocrinol Metab85200030533057
   PubMed Web of Science ®Google Scholar
• RxList. Dostinex (cabergoline); 2016. Available at: http://www.rxlist.com/dostinex-drug.htm. Accessed October 2017.
   Google Scholar
• RxList. Cycloset (bromocriptine mesylate tablets), 2017. Available at: http://https://www.rxlist.com/cycloset-drug.htm. Accessed October 2017.
   Google Scholar
• A.BarlierP.JaquetQuinagolide – a valuable treatment option for hyperprolactinaemiaEur J Endocrinol1542006187195
   PubMed Web of Science ®Google Scholar
• A.ColaoA.Di SarnoP.CappabiancaC.Di SommaR.PivonelloG.LombardiWithdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemiaN Engl J Med349200320232033
   PubMed Web of Science ®Google Scholar
• M.P.GillamM.E.MolitchG.LombardiA.ColaoAdvances in the treatment of prolactinomasEndocr Rev272006485534
   PubMed Web of Science ®Google Scholar
• Brada M, Jankowska P. Radiotherapy for pituitary adenomas. Endocrinol Metab Clin North Am 2008;37:263–75, xi.
   Google Scholar
• T.W.WongT.M.JonesHyperprolactinemia and male infertilityArch Pathol Lab Med10819843539
   Web of Science ®Google Scholar
• S.SegalH.YaffeN.LauferM.Ben-DavidMale hyperprolactinemia:effects on fertilityFertil Steril321979556561
   PubMed Web of Science ®Google Scholar
• C.A.AdejuwonA.O.IlesanmiE.O.OdeHyperprolactinaemia as a cause of male infertility in IbadanWest Afr J Med1819991719
   PubMedGoogle Scholar
• G.F.GonzalesM.Garcia-HjarlesG.VelasquezHyperprolactinaemia and hyperserotoninaemia: their relationship to seminal qualityAndrologia24199295100
   PubMed Web of Science ®Google Scholar
• J.M.Soler FernándezF.Caravaca MagariñosC.Domínguez BravoHerreraPuertoCorrelation of serum prolactin, sperm count and motility. Prevalence of hyperprolactinemia in the infertile maleJ Arch Esp Urol431990891895
   Google Scholar
• F.LottiG.CoronaE.MaseroliM.RossiA.SilveriiS.Degl'innocentiet alClinical implications of measuring prolactin levels in males of infertile couplesAndrology12013764771
   PubMed Web of Science ®Google Scholar
• H.OkadaT.IwamotoH.FujiokaT.ShirakawaN.TatsumiM.Kanzakiet alHyperprolactinaemia among infertile patients and its effect on sperm functionsAndrologia281996197202
   PubMed Web of Science ®Google Scholar
• S.MićićR.DotlićV.IlićO.GenbacevHormone profile in hyperprolactinemic infertile menArch Androl151985123128
   PubMedGoogle Scholar